X

Company profile for Jiangsu Hansyn Pharmaceutical Co Ltd

Jiangsu Hansyn Pharmaceutical Co Ltd

JIANGSU HANSYN PHARMACEUTICAL CO LTD

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

No Content

APIs // Active Pharmaceutical Ingredients

1 APIs, 1 USDMF

DEVELOPMENTS

No Content

Contact Supplier

Related Companies

Hengsheng Pharmaceutical a high-tech joint-stock enterprises, the main investor in Jiangsu Huachang Group under the "Heng investment" and Nanjing "Ruihua Holding", etc., have proficient domestic and international pharmaceutical business and localization of international management team, now There are more than 300 employees, in the rapid development of transition. The company's existing business with annual sales of nearly 300...

Hengsheng Pharmaceutical a high-tech joint-stock enterprises, the main investor in Jiangsu Huachang Group under the "Heng investment" and Nanjing "Ruihua Holding", etc., have proficient domestic and international pharmaceutical business and localization of international management team, now There are more than 300 employees, in the rapid development of transition. The company's existing business with annual sales of nearly 300 million yuan, the implementation of the new bio-pharmaceutical R & D and production projects (a total investment of 3.5 billion), will promote the company to become an international standard, a combination of standardized procurement of raw materials, technology development, cGMP manufacturing , admission regulations and global marketing of pharmaceutical company focused on respiratory disease and metabolic disease treatment drug industries value integration and technological innovation. Business body contains Zhangjiagang Yangtze River International Industrial Park, Suzhou manufacturing and R & D amplification base, located in Xuhui District of Shanghai Juke Biotech Park, a business research and development centers, as well as mergers and acquisitions of other pharmaceutical business.